- Home
- ARDC vs JSPR Comparison
ARDC vs JSPR Comparison
Compare ARDC & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARDC
- JSPR
- Stock Information
- Founded
- ARDC 2012
- JSPR 2018
- Country
- ARDC United States
- JSPR United States
- Employees
- ARDC N/A
- JSPR 45
- Industry
- ARDC Investment Managers
- JSPR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ARDC Finance
- JSPR Health Care
- Exchange
- ARDC Nasdaq
- JSPR Nasdaq
- Market Cap
- ARDC 342.8M
- JSPR 323.6M
- IPO Year
- ARDC N/A
- JSPR N/A
- Fundamental
- Price
- ARDC $14.99
- JSPR $21.57
- Analyst Decision
- ARDC
- JSPR Strong Buy
- Analyst Count
- ARDC 0
- JSPR 11
- Target Price
- ARDC N/A
- JSPR $73.38
- AVG Volume (30 Days)
- ARDC 115.8K
- JSPR 181.9K
- Earning Date
- ARDC 01-01-0001
- JSPR 11-07-2024
- Dividend Yield
- ARDC 9.84%
- JSPR N/A
- EPS Growth
- ARDC N/A
- JSPR N/A
- EPS
- ARDC N/A
- JSPR N/A
- Revenue
- ARDC N/A
- JSPR N/A
- Revenue This Year
- ARDC N/A
- JSPR N/A
- Revenue Next Year
- ARDC N/A
- JSPR N/A
- P/E Ratio
- ARDC N/A
- JSPR N/A
- Revenue Growth
- ARDC N/A
- JSPR N/A
- 52 Week Low
- ARDC $11.56
- JSPR $5.00
- 52 Week High
- ARDC $14.30
- JSPR $31.01
- Technical
- Relative Strength Index (RSI)
- ARDC 35.05
- JSPR 48.67
- Support Level
- ARDC $15.22
- JSPR $20.12
- Resistance Level
- ARDC $15.39
- JSPR $23.11
- Average True Range (ATR)
- ARDC 0.19
- JSPR 1.77
- MACD
- ARDC -0.05
- JSPR -0.16
- Stochastic Oscillator
- ARDC 33.13
- JSPR 32.53
About ARDC Ares Dynamic Credit Allocation Fund Inc.
Ares Dynamic Credit Allocation Fund Inc is a closed-ended, diversified management investment company. The fund's investment objective is to provide an attractive level of total return, through current income and, secondarily, through capital appreciation. The Fund invests in a broad, dynamically managed portfolio of senior secured loans (Senior Loans) made to companies whose debt is rated below investment grade; corporate bonds (Corporate Bonds) that are high yield issues rated below investment grade; other fixed-income instruments of a similar nature that may be represented by derivatives; and securities of collateralized loan obligations (CLOs).
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.